USPatent applicationPatented

Microcapsule compositions and the method of their release

Granted 10 Sep 2019 · 1 office action

Current assignee: Rohm And Haas Company · originally DuPont

Law firm: Law firm · Log in to unlock

Attorney: Attorney · Log in to unlock

Inventors: Hsuan-Chin Wang, Steven C. Zimmerman, David M. Laganella · Examiner: Nissa M Westerberg · AU 1618 · TC 1600

Life of the application

11 dated events
⤢ drag to zoom201620182020202220242026202820302032203420362038ProsecutionOwnershipTerm & fees
ProsecutionOwnershipTerm & feeshover for detail · click to open

Abstract

The present invention provides microcapsules with good barrier properties and the ability to release encapsulated hydrophobic liquids at low and high pH.

Description

3 parts
›This invention relates to microcapsule compositions which have…

This invention relates to microcapsule compositions which have the ability to provide for a pH triggered release of hydrophobic liquids.

High capacity, thin-shell microcapsules with good barrier properties and the ability to release encapsulated actives at the desired rates upon application of suitable triggers are in high demand in industrial settings. Attempts to make pH triggered encapsulates exist in the art. U.S. Pat. No. 6,022,501 describes using excess acid halides to generate carboxylic acid groups in microcapsule shells. Although U.S. Pat. No. 6,022,501 describes a triggered release system, such a system utilizes pH greater than 5.9 as the trigger. Additionally, in the prior art relatively few compositions describe an alkaline/high pH triggered release. Rarer still is the use of both high and low pH to trigger degradation/release in a single system; most of these are polyampholyte-based encapsulants.

What is needed in the art is the ability for the same microcapsule chemistry to be utilized in triggered-release applications under different pH environments without the need for different encapsulation/triggered release strategies. The present invention solves the deficiencies of the art.

The present invention provides a microcapsule composition comprising a core comprising a hydrophobic liquid; and a shell comprising the reaction product of at least one simple diester diacid chloride monomer and at least one polyamine.

The present invention also provides a method of releasing a hydrophobic liquid wherein the method comprises placing a microcapsule composition comprising a core comprising a hydrophobic liquid; and a shell comprising the reaction product of at least one simple diester diacid chloride monomer and at least one polyamine into an aqueous environment having a pH of 9 or greater.

The present invention also provides a method of releasing a hydrophobic liquid wherein the method comprises placing a microcapsule composition comprising a core comprising a hydrophobic liquid; and a shell comprising the reaction product of at least one simple diester diacid chloride monomer and at least one polyamine into an aqueous environment having a pH of 6 or less.

As used herein by “hydrophobic liquid” is meant a water insoluble compound that is a liquid at the reaction temperature or a water insoluble compound dissolved in a hydrophobic solvent that is liquid at the reaction temperature.

As used herein by “hydrophobic solvent” is meant a liquid that has a solubility in water of less than 5%.

As used herein by “high pH” is meant pH of 8 or greater, preferably pH 9 to 12, more preferably pH 10 to 11.

As used herein by “low pH” is meant pH of 6 or lower, preferably pH 4 to 6 more preferably pH 4 to 5.

As used herein by “neutral pH” is meant pH of greater than 6 to less than 8, preferably 7-8.

As used herein “microcapsules” and “microencapsulated compositions” are used interchangeably.

As used herein by “reaction temperature” is the temperature at which the simple diester diacid chloride monomer and the polyamine are reacted to form the shell. Suitable temperatures include 0-99° C., alternatively 15-60° C., further alternatively 20-50° C., and further alternatively 40-50° C.

As used herein by “water insoluble” is meant a solubility of less than 5% and more particularly less than 2% in water at room temperature.

Microcapsule compositions of the present invention comprise a core and a shell wherein the shell comprises the reaction product of at least one simple diester diacid chloride monomer and at least one polyamine. A particularly useful diester diacid chloride monomer of the present invention is pyromellitic diester diacid chloride (PDDC) and particularly useful polyamines of the present invention are N,N′,N″-tris(2-aminoethyl)-1,3,5-triazine-2,4,6-triamine (triazine) and diethylenetriamine (DETA). The core of the microcapsule compositions is comprised of a hydrophobic liquid.

The microcapsule compositions of the present invention encapsulate in its core hydrophobic liquids. Examples of suitable hydrophobic liquids in this encapsulated liquid core include but are not limited to 4,5-dichloro-2-n-octyl-3(2H)-isothiazolone (DCOIT), 2-n-octyl-3(2H)-isothiazolone (OIT) and benzisothiazolone (BIT), lodopropargyl butyl carbamate (IPBC), Propiconazole, N(trichloromethylthio)pthalimide, methyl benzimidazol-2-yl carbamate, tetrachloroisophthalonitrile, Dibromonitriloproprianamide (DBNPA), 2-(thiocyanomethylthio)benzothiazole (TCMTB), Tebuconazole, Tributyl tin benzoate, Parabens, 2,5-dimethyl-N-cyclohexyl-N-methoxy-3-furan carboxamide, 5-Ethoxy-3-trichloromethyl-1,2,4 thiadiazole, 3-(2-methyl piperidino) propyl 3,4-dichlorobenzoate, N,N′-(1,4-piperazinediyl bis (2,2,2-trichloro)ethylidene) bis formamide, Tetramethyl thiuram disulfide, 0-Ethyl-S,S,diphenyl-dithiophosphate, 5,10-dihydro-5,10-dioxo naphtho (2,3,9)-p-dithiin-2,3-dicarbonitrile, .alpha.-2-[(4-chlorophenyl)ethyl]-.alpha.-(1,1-dimethyl ethyl)-1H-1,2,4-triazole-1-ethanol 3-(3,4-dichlorophenyl)1,1 dimethylurea, N-tridecyl-2,6-dimethylmorpholine and 4-N-dodecyl-2,6-dimethylmorpholine or solutions thereof. A particularly preferred hydrophobic liquid is—dichloro-2-n-octyl-3(2H)-isothiazolone (DCOIT). The hydrophobic liquid may be present in the core alone or in combination with a hydrophobic solvent either as a mixture or as a dispersion. The encapsulated liquid core comprises up to 95% of the total microcapsule capsule weight. Advantageously, the hydrophobic liquid does not release from the core when the microcapsules of the present invention are suspended in hydrophobic solvent. Such hydrophobic solvent may be, for example, toluene, xylenes, ethyl acetate, hexanes, heptanes, benzene, naphthalene, 2-butanone, or mixtures thereof.

The resultant microcapsule compositions of the present invention have capsule diameters between 200 and 350 μm, with shell thicknesses in the range of 0.8-1.5 μm. Capsules outside of this size range are easily envisioned by one skilled in the art. Detailed characterization of capsule morphology, size, and shell-thickness was performed by scanning electron microscopy (SEM). The shell-thickness was determined by cutting capsules with a razor blade and imaging the cross-section. These compositions exhibit resistance to leakage in dry or non-polar environments, and demonstrate pH tunable release of hydrophobic liquids at high and low pH. Particularly interesting is the microcapsule composition's ability to undergo accelerated release of a small molecule active at high and low pH's, while at neutral/physiological pH, sustain a steady release profile. Such capability allows the same microcapsule chemistry to be utilized in triggered-release applications under different pH environments without the need for different encapsulation/triggered release strategies.

›The hydrophobic liquids described herein may be released…

The hydrophobic liquids described herein may be released from the microcapsules by placing them either in high or low pH aqueous environments. Any aqueous environment which has either a high or low pH is suitable. Non-limiting pH ranges suitable for the present invention include pH 9 or greater and 6 or lower; however, all ranges in the definition of high and low pH are contemplated.

›EXAMPLES

Method of Making:

The microcapsules of the present invention were prepared by interfacial polymerization based on a slight modification of procedure reported by Frechet in Broaders, K. E.; Pastine, S. J.; Grandhe, S.; Fréchet, J. M. J. Chemical Communications 2011, 47, 665. A saturated solution of pyromellitic diester diacid chloride (PDDC) in toluene was emulsified with an aqueous 0.4 w/w % polyvinyl alcohol solution with magnetic stirring to produce a suspension of oil-in-water emulsion droplets, whose shapes and sizes determine the final capsule dimensions. Dropwise addition of an aqueous solution of the hydrophilic monomers, triazine and DETA initiated the polycondensation reactions at the water-oil interface to form a cross-linked polyamide shell. Maturation for 60 min afforded a suspension of microcapsules that were vacuum filtered, rinsed with DI water and acetone, and allowed to dry in air to give a white, free flowing powder.

The percent of hydrophobic liquid dye solution, comprising a dye mixed with toluene, released at various points in time at low, neutral, and high pH is captured in the tables below.

›Tables in the description — 3
TABLE 1 — 1:1 Triazine:DETA - terephthaloyl chloride (TC) (Control)
Time (h)pH 5pH 7pH 10Toluene
2−2.65−3.06−2.74−4.86
120.70−1.45−0.18−4.30
243.66−0.162.23−3.56
505.920.643.82−4.12
725.330.324.63−5.81
966.06−0.165.91−5.80
1209.452.259.44−4.12
TABLE 2 — 3:1 Triazine:DETA - PDDC
Time (h)pH 5pH 7pH 10Toluene
32.800.271.88−2.42
1310.793.848.99−1.83
2421.446.9222.85−2.56
4839.7114.0460.19−2.79
7254.5822.3586.51−2.08
9664.9731.5096.82−2.29
12072.1141.60100.35−1.39
TABLE 3 — 1:1 Triazine:DETA - PDDC
Time (h)pH 5pH 7pH 10Toluene
34.76−3.963.66−3.29
1326.661.1930.58−3.69
2451.469.7969.54−3.83
4883.8935.7197.54−4.24
7298.4166.52101.38−3.27
96101.6190.05100.67−3.42
120104.43103.27102.45−3.41
2 of 3 part labels are ours — the grant heads the rest

Claims as granted

6 claims

Log in to read the claims of this application.

Log in to unlock

Classifications

5 codes
IPC · International Patent Classification
Section A — Human necessities
  • A01N37/10
  • A01N33/04
  • A01N43/80
  • A01N43/68
  • A01N25/28

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this application are not paired with the granted ones in what we hold.

File wrapper

⤢ drag to zoomOct 2017Jan 2018Apr 2018Jul 2018Oct 2018Jan 2019Apr 2019Jul 2019Oct 2019USPTOApplicantRestriction requirementNotice of allowance
USPTOApplicanthover for detail · click to open
Pendency
1.9 y
699 days filing → grant
Office actions
0
after a restriction
Examiner
Nissa M Westerberg
art unit 1618 · TC 1600
Citations: 5 back · 0 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Log in to unlock

Documents

Log in to open the documents of this file: the application as filed, every office action and response, the notice of allowance.

Log in to unlock

Chain of title

⤢ drag to zoom2020202220242026202820302032203420362038Owner 3
Titlehover for detail · click to open

See the full assignment history — every owner this patent has passed through, with recordation dates and reel/frame numbers.

Log in to unlock